CIK 0001716166
- Non-accelerated filer
- Smaller reporting company
Vivos Therapeutics, Inc.
Sign in to watch- Ticker
- VVOS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813224056
- Phone
- +1 866-908-4867
- Business address
- 7921 SOUTHPARK PLAZA,, SUITE 210, LITTLETON, CO, 80120
- Former names
- Vivos BioTechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Huntsman Ronald Kirk Chief Executive Officer | Other acquisition | +85,910 | $0.58 | $50K | 85,910 |
| 2026-06-30 | Huntsman Ronald Kirk Chief Executive Officer | Other acquisition · Warrant (Right to Buy) | +85,910 | $0.58 | $50K | 85,910 |
| 2024-11-26 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +315,421 | $2.64 | $833K | 364,755 |
| 2024-06-20 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | $2.38 | $48K | 49,334 |
| 2023-06-20 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +14,000 | $0.53 | $7K | 86,521 |
| 2023-06-16 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +10,000 | $0.54 | $5K | 67,521 |
| 2023-06-16 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +5,000 | $0.53 | $3K | 72,521 |
| 2023-06-15 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +21 | $0.50 | $11 | 57,521 |
| 2023-06-14 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +10,000 | $0.49 | $5K | 57,500 |
| 2022-12-23 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +20,000 | $0.50 | $10K | 47,500 |
| 2022-12-23 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +333,334 | $0.48 | $160K | 333,334 |
| 2022-12-23 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | $0.48 | $72K | 483,334 |
| 2022-06-01 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +4,000 | $1.83 | $7K | 27,500 |
| 2022-05-31 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +8,000 | $2.03 | $16K | 23,500 |
| 2022-02-25 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | $3.27 | $409K | 125,000 |
| 2021-09-21 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +5,000 | $4.31 | $22K | 15,500 |
| 2021-08-17 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +5,000 | $3.00 | $15K | 10,500 |
| 2021-05-25 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +4,000 | $5.38 | $22K | 5,500 |
| 2020-12-23 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +1,000 | $7.27 | $7K | 1,500 |
| 2020-12-11 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +500 | $8.50 | $4K | 500 |
Page 1 of 1 · 20 trades